With the sharp downturn in the financial markets, BioInform decided to take a look at how bioinformatics stocks were faring. Unfortunately, the news isn’t good. Shares of all five of the bioinformatics companies that went public in 2000 are currently trading below the closing price on their first day of trading.
Of course, these companies still have something to smile about — they’ve got loads of IPO cash in the bank. Other bioinformatics companies such as DoubleTwist and NetGenics have withdrawn their offerings and undergone layoffs as they try to ride out the storm as privately held companies.